Emergent Biosolutions Inc/ US29089Q1058 /
2024-03-28 9:10:00 PM | Chg. -0.06 | Volume | Bid12:12:03 AM | Ask12:12:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
2.53USD | -2.32% | 1.09 mill. Turnover: 2.44 mill. |
2.55Bid Size: 800 | 2.71Ask Size: 3,700 | 132.07 mill.USD | - | - |
GlobeNewswire
03-28
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray...
GlobeNewswire
03-25
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
GlobeNewswire
03-20
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
GlobeNewswire
02-29
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conf...
GlobeNewswire
02-29
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
GlobeNewswire
02-21
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
GlobeNewswire
01-11
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (...
GlobeNewswire
01-09
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11,...
GlobeNewswire
2023-11-28
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ ...
GlobeNewswire
2023-11-24
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing
GlobeNewswire
2023-10-30
UPDATE: Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference...
GlobeNewswire
2023-10-19
Emergent BioSolutions to Release Third Quarter 2023 Financial Results and Conduct Conference Call on...
GlobeNewswire
2023-10-02
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
GlobeNewswire
2023-09-20
SHAREHOLDER ALERT: Morris Kandinov Investigating EBS, JRVR, EGIO, and HAFC; Shareholders are Encoura...
GlobeNewswire
2023-09-13
Myricx Expands its Leadership Team with the Appointment of Dr. Robert McLeod as VP Clinical Developm...
GlobeNewswire
2023-08-30
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone...
GlobeNewswire
2022-03-15
Opiant Pharmaceuticals Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Co...